First AI-Designed Phage Therapy Administered to Patient with Drug-Resistant Infection

A San Francisco-based company announced the first-ever administration of an AI-designed bacteriophage to treat a patient with an antibiotic-resistant bacterial infection. The treatment's efficacy remains unproven, and the company's claim of a first is unverified. This marks a novel convergence of AI and precision medicine, potentially offering a new avenue against antimicrobial resistance.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works